Pharming Group Submits European Marketing Authorization Procedure Request for Rhucin

AMSTERDAM (Thomson Financial) - Pharming Group NV said it has submitted a request to the European Medicines Agency (EMEA) to reexamine its application to market its lead product Rhucin, which was rejected earlier this month.